| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 1,100 | 1,100 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS | 2024-07 | PURCHASE | 2025-07 | 6,926 | 6,614 | 312 | ||||
| UNITEDHEALTH GROUP INC | 2024-05 | PURCHASE | 2025-03 | 3,364 | 3,581 | -217 | ||||
| DYNATRACE INC | 2024-05 | PURCHASE | 2025-08 | 5,077 | 4,618 | 459 | ||||
| INMODE LTD | 2023-07 | PURCHASE | 2025-07 | 2,607 | 7,706 | -5,099 | ||||
| SALESFORCE INC | 2022-03 | PURCHASE | 2025-07 | 11,734 | 8,792 | 2,942 | ||||
| UNITEDHEALTH GROUP INC | 2022-06 | PURCHASE | 2025-02 | 7,088 | 6,813 | 275 | ||||
| UNITEDHEALTH GROUP INC | 2022-06 | PURCHASE | 2025-03 | 3,364 | 3,407 | -43 | ||||
| HALOZYME THERAPEUTICS | 2024-08 | PURCHASE | 2025-07 | 7,159 | 6,848 | 311 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| EQUITIES | 239,120 | 448,989 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| EXCHANGE TRADED FUNDS | AT COST | 11,980 | 12,038 |
| FIXED INCOME | AT COST | 49,957 | 50,436 |
| Description | Amount |
|---|---|
| ADJUSTMENT FOR COST BASIS | 428 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| FOREIGN TAXES PAID | 5 | 5 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ADVISORY FEES | 3,571 | 3,571 | ||
| ATTORNEY FEES | 174 | 174 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES PAID | 33 | 33 |